Recombinant factor VIIa (NovoSeven®) as a hemostatic agent

[1] ABERG M, 1978, ANN SURG, V189, P243

[2] BAJZAR L, 1993, J BIOL CHEM, V268, P8608

[3] BECH R, 1989, THROMB HAEMOSTASIS, V62, P55

[4] Beguin S, 1997, THROMB HAEMOSTASIS, V78, P590

[5] BEGUIN S, 1989, THROMB HAEMOSTASIS, V61, P25

[6] Recombinant factor VIIa corrects prothrombin time in cirrhotic patients: A preliminary study [J]. GASTROENTEROLOGY, 1997, 113 (06) : 1930 - 1937

[7] NovoSeven® in warfarin-treated patients [J]. BLOOD COAGULATION & FIBRINOLYSIS, 2000, 11 : S113 - S115

[8] BIGGS R, 1962, HUMAN BLOOD COAGULAT

[9] FIBRIN IN HUMAN PLASMA - GEL ARCHITECTURES GOVERNED BY RATE AND NATURE OF FIBRINOGEN ACTIVATION [J]. THROMBOSIS RESEARCH, 1994, 75 (05) : 521 - 538

[10] Coagulation-dependent inhibition of fibrinolysis: Role of carboxypeptidase-U and the premature lysis of clots from hemophilic plasma [J]. BLOOD, 1996, 88 (10) : 3815 - 3823

[1] ABERG M, 1978, ANN SURG, V189, P243

[2] BAJZAR L, 1993, J BIOL CHEM, V268, P8608

[3] BECH R, 1989, THROMB HAEMOSTASIS, V62, P55

[4] Beguin S, 1997, THROMB HAEMOSTASIS, V78, P590

[5] BEGUIN S, 1989, THROMB HAEMOSTASIS, V61, P25

[6] Recombinant factor VIIa corrects prothrombin time in cirrhotic patients: A preliminary study [J]. GASTROENTEROLOGY, 1997, 113 (06) : 1930 - 1937

[7] NovoSeven® in warfarin-treated patients [J]. BLOOD COAGULATION & FIBRINOLYSIS, 2000, 11 : S113 - S115

[8] BIGGS R, 1962, HUMAN BLOOD COAGULAT

[9] FIBRIN IN HUMAN PLASMA - GEL ARCHITECTURES GOVERNED BY RATE AND NATURE OF FIBRINOGEN ACTIVATION [J]. THROMBOSIS RESEARCH, 1994, 75 (05) : 521 - 538

[10] Coagulation-dependent inhibition of fibrinolysis: Role of carboxypeptidase-U and the premature lysis of clots from hemophilic plasma [J]. BLOOD, 1996, 88 (10) : 3815 - 3823